POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY

K. B. Lauridsen; K. Duch; A. S. Mortensen; R. Cordtz; S. Kristensen; M. L. Hetland; L. Dreyer

doi:10.1136/annrheumdis-2023-eular.1521

POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY

K. B. Lauridsen, K. Duch, A. S. Mortensen, R. Cordtz, S. Kristensen, M. L. Hetland, L. Dreyer

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	POS0173
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	82
Udgave nummer	Suppl. 1
Sider (fra-til)	310-311
Antal sider	2
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2023-eular.1521
Status	Udgivet - jun. 2023
Begivenhed	EULAR 2023 European Congress of Rheumatology - Milan, Italien Varighed: 31 maj 2023 → 3 jun. 2023 https://congress.eular.org/index.cfm

Konference

Konference	EULAR 2023 European Congress of Rheumatology
Land/Område	Italien
By	Milan
Periode	31/05/2023 → 03/06/2023
Internetadresse	https://congress.eular.org/index.cfm

Bibliografisk note

Abstrakt No. POS0173

Adgang til dokumentet

10.1136/annrheumdis-2023-eular.1521

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Lauridsen, K. B., Duch, K., Mortensen, A. S., Cordtz, R., Kristensen, S., Hetland, M. L., & Dreyer, L. (2023). POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY. Annals of the Rheumatic Diseases, 82(Suppl. 1), 310-311. Artikel POS0173. https://doi.org/10.1136/annrheumdis-2023-eular.1521

@article{6d8310a3811343a08b9484f3af1d1e77,

title = "POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY",

author = "Lauridsen, {K. B.} and K. Duch and Mortensen, {A. S.} and R. Cordtz and S. Kristensen and Hetland, {M. L.} and L. Dreyer",

note = "Abstract No. POS0173; EULAR 2023 European Congress of Rheumatology ; Conference date: 31-05-2023 Through 03-06-2023",

year = "2023",

month = jun,

doi = "10.1136/annrheumdis-2023-eular.1521",

language = "English",

volume = "82",

pages = "310--311",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

url = "https://congress.eular.org/index.cfm",

}

Lauridsen, KB , Duch, K , Mortensen, AS , Cordtz, R , Kristensen, S, Hetland, ML & Dreyer, L 2023, 'POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY', Annals of the Rheumatic Diseases, bind 82, nr. Suppl. 1, POS0173, s. 310-311. https://doi.org/10.1136/annrheumdis-2023-eular.1521

POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY. / Lauridsen, K. B.; Duch, K.; Mortensen, A. S. et al.
I: Annals of the Rheumatic Diseases, Bind 82, Nr. Suppl. 1, POS0173, 06.2023, s. 310-311.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - POS0173 GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY

AU - Lauridsen, K. B.

AU - Duch, K.

AU - Mortensen, A. S.

AU - Cordtz, R.

AU - Kristensen, S.

AU - Hetland, M. L.

AU - Dreyer, L.

N1 - Abstract No. POS0173

PY - 2023/6

Y1 - 2023/6

U2 - 10.1136/annrheumdis-2023-eular.1521

DO - 10.1136/annrheumdis-2023-eular.1521

M3 - Conference abstract in journal

SN - 0003-4967

VL - 82

SP - 310

EP - 311

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - POS0173

T2 - EULAR 2023 European Congress of Rheumatology

Y2 - 31 May 2023 through 3 June 2023

ER -